Neuronetics Reports Strong Q4 2025 Revenue Growth and Achieves Positive Operating Cash Flow

summarizeSummary

Neuronetics, Inc. reported preliminary Q4 2025 revenue of $41.8 million, marking 86% year-over-year growth, and achieved positive operating cash flow of $0.9 million, ending the year with $34.1 million in cash.

check_boxKey Events

• Strong Fourth Quarter Revenue Growth

  Reported preliminary unaudited Q4 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as-reported basis and 23% year-over-year growth on an adjusted pro forma basis.

• Full Year Revenue Exceeds Expectations

  Achieved preliminary unaudited full year 2025 revenue of $149.2 million, a 99% increase year-over-year as reported and 15% increase on an adjusted pro forma basis.

• Positive Operating Cash Flow

  Generated positive operating cash flow of $0.9 million in the fourth quarter of 2025, a significant financial milestone.

• Healthy Cash Position

  Ended 2025 with a total cash balance of $34.1 million, inclusive of cash, cash equivalents, and restricted cash.

auto_awesomeAnalysis

Neuronetics, Inc. announced preliminary unaudited financial results for the fourth quarter and full year 2025, demonstrating significant commercial execution and improved financial health. The company achieved substantial revenue growth, both on an as-reported and adjusted pro forma basis, indicating strong performance following the Greenbrook acquisition. Critically, Neuronetics generated positive operating cash flow in Q4 2025, a key milestone that suggests improved operational efficiency and financial stability. The healthy cash balance at year-end further strengthens its position as it moves into 2026. These results provide a positive outlook for the company's ability to execute its strategy and manage its financial runway.